Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes

PURPOSE: To assess the safety of biosimilar intravitreal aflibercept (CinnaGen Co., Iran) compared to the reference product (Eylea®; Bayer Schweiz AG, Zurich, Switzerland) in rabbit eyes through functional and histologic studies. METHODS: Forty New Zealand albino rabbits were recruited to the study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Ophthalmol
Autors principals: Lashay, Alireza, Riazi-Esfahani, Hamid, Faghihi, Hooshang, Mirshahi, Ahmad, Khojasteh, Hassan, Khodabande, Alireza, Amoli, Fahimeh Asadi, Ghassemi, Fariba, Bazvand, Fatemeh, Khalili Pour, Elias, Ebrahimiadib, Nazanin, Torkashvand, Ali, Delrish, Elham
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7354659/
https://ncbi.nlm.nih.gov/pubmed/32714608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2602918
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars